{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-116342","form_type":"8-K","ticker":null,"cik":"0001633070","company_name":"Axcella Health Inc.","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.848605+00:00","generated_at":"2026-06-08T06:48:48.240169+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.95,"calibrated_materiality_score":0.95,"confidence":"high","headline":"Nasdaq notifies Axcella of delisting risk; company deemed public shell after board resignations and dissolution plan","bullets":["On Nov 8, 2023, Nasdaq Staff notified Axcella it is a 'public shell' due to asset transfer for creditor benefit, dissolution plan, and board/executive departures.","Ten directors resigned effective Nov 1, 2023, including CEO and Chief Legal Officer; executive team terminated.","Non-compliance with minimum Market Value of Listed Securities ($50M) and Market Value of Publicly Held Shares ($15M) after 180-day grace period.","Also non-compliance with independent board and committee composition requirements under Nasdaq Listing Rules 5605.","Nasdaq Hearings Panel will consider continued listing; company faces potential delisting."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-116342","json":"https://secwatch.observer/filing/0001104659-23-116342.json","markdown":"https://secwatch.observer/filing/0001104659-23-116342.md","text":"https://secwatch.observer/filing/0001104659-23-116342.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1633070/000110465923116342/0001104659-23-116342-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1633070/000110465923116342/tm2330301d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T06:48:48.240169+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d7acbbd28437013dfbbd93c55efc9e2202a3c94a","claim":"Axcella Health Inc. received a nasdaq noncompliance notice notice regarding market value (rules 5101).","evidence_excerpt":"ffective November 1, 2023 (the “Board Resignations”); and (iii) termination of the Company’s executive team, including the Chief Executive Officer and Chief Legal Officer and Corporate Secretary, it is the Staff’s belief that the Company is a “public shell” as that term is defined in Nasdaq Listing Rule 5101. The Staff also expressed concerns relating to the Company’s non-compliance with all requirements for continued listing on the Nasdaq, including for failing to regain compliance with the $50,000,000 minimum Market Value of Listed Securities and $15,000,000 minimum Market Value of Publicly","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1633070/000110465923116342/0001104659-23-116342-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"noncompliance notice"},{"label":"Deficiency","value":"market value"},{"label":"Rules","value":"5101"}],"fact_type":"exchange_compliance_notice"},{"claim_id":"fdd07e80d29513da0c9506dbbfd660d7074a4891","claim":"Axcella Health Inc. received a nasdaq deficiency notice notice regarding other (rules 5101, 5605(b)(1), 5605(c)(2), 5605(d)(2), 5605(e)(1)).","evidence_excerpt":"ffective November 1, 2023 (the “Board Resignations”); and (iii) termination of the Company’s executive team, including the Chief Executive Officer and Chief Legal Officer and Corporate Secretary, it is the Staff’s belief that the Company is a “public shell” as that term is defined in Nasdaq Listing Rule 5101. The Staff also expressed concerns relating to the Company’s non-compliance with all requirements for continued listing on the Nasdaq, including for failing to regain compliance with the $50,000,000 minimum Market Value of Listed Securities and $15,000,000 minimum Market Value of Publicly","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1633070/000110465923116342/0001104659-23-116342-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Rules","value":"5101, 5605(b)(1), 5605(c)(2), 5605(d)(2), 5605(e)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}